Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Saad

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
ACS Infectious Diseases|November 14, 2019
Balancing Physicochemical Properties of Phenylthiazole Compounds with Antibacterial Potency by Modifying the Lipophilic Side ChainAhmed Mancy, Nader S Abutaleb, Mohamed M Elsebaei, et al.
Archiv Der Pharmazie|July 1, 2025
Development of New Thiadiazole Derivatives as VEGFR-2 Inhibitors With Anticancer and Proapoptotic Activities‏Hazem Elkady, Walid E Elgammal, Mohamed M Khalifa, et al.
Molecular Therapy. Methods & Clinical Development|February 2, 2018
Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHDLindsay M Wallace, Nizar Y Saad, Nettie K Pyne, et al.
Annals of Clinical and Translational Neurology|May 21, 2026
Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHDMustafa Bilal Bayazit, Chiranth K Nagaraj, Jackson S Newell, et al.
Annals of Neurology|May 15, 2023
Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell ModelsRenatta N Knox, Jocelyn O Eidahl, Lindsay M Wallace, et al.
Molecular Therapy. Nucleic Acids|April 8, 2026
Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1AMarina Stavrou, Lindsay M Wallace, Merlin P Thangaraj, et al.
JCI Insight|November 16, 2018
AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHDCarlee R Giesige, Lindsay M Wallace, Kristin N Heller, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
ACS Infectious Diseases|November 14, 2019
Balancing Physicochemical Properties of Phenylthiazole Compounds with Antibacterial Potency by Modifying the Lipophilic Side ChainAhmed Mancy, Nader S Abutaleb, Mohamed M Elsebaei, et al.
Archiv Der Pharmazie|July 1, 2025
Development of New Thiadiazole Derivatives as VEGFR-2 Inhibitors With Anticancer and Proapoptotic Activities‏Hazem Elkady, Walid E Elgammal, Mohamed M Khalifa, et al.
Molecular Therapy. Methods & Clinical Development|February 2, 2018
Pre-clinical Safety and Off-Target Studies to Support Translation of AAV-Mediated RNAi Therapy for FSHDLindsay M Wallace, Nizar Y Saad, Nettie K Pyne, et al.
Annals of Clinical and Translational Neurology|May 21, 2026
Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHDMustafa Bilal Bayazit, Chiranth K Nagaraj, Jackson S Newell, et al.
Annals of Neurology|May 15, 2023
Post-Translational Modifications of the DUX4 Protein Impact Toxic Function in FSHD Cell ModelsRenatta N Knox, Jocelyn O Eidahl, Lindsay M Wallace, et al.
Molecular Therapy. Nucleic Acids|April 8, 2026
Safety, efficacy, and distal nerve Schwann cell biodistribution in mice and NHPs to support translation of AAV9 RNAi therapy for CMT1AMarina Stavrou, Lindsay M Wallace, Merlin P Thangaraj, et al.
JCI Insight|November 16, 2018
AAV-mediated follistatin gene therapy improves functional outcomes in the TIC-DUX4 mouse model of FSHDCarlee R Giesige, Lindsay M Wallace, Kristin N Heller, et al.
Pageof 9